secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENERON PHARMACEUTICALS, INC. (REGN)
CIK:        0000872589
Form:       8-K
Filed at:   2022-12-20T23:59:59+00:00
Accession:  0001104659-22-128613
Event type: debt
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 1.02, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Regeneron enters into new $750M revolving credit facility, replaces prior facility
--------------------------------------------------------------------------------

- New $750M senior unsecured five-year revolving credit facility maturing Dec 19, 2027.
- Interest rate variable: SOFR or alternate base rate plus margin tied to debt rating and leverage ratio.
- Includes $500M accordion to increase commitments or add term loans with lender consent.
- ESG amendment option to adjust pricing based on environmental, social, governance targets.
- No borrowings outstanding at closing; prior $750M facility terminated simultaneously.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/872589/000110465922128613/0001104659-22-128613-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/872589/000110465922128613/tm2233051d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-128613

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer